Latest Sales Growth News

Freehill Mining’s aggregates business posted a record $1.36 million in quarterly sales, up 47% from the prior quarter, driven by plant improvements and a broadening customer base. June alone saw a record $496,000 in sales, underpinning the company’s copper project ambitions.

Within six weeks of commissioning, Aguia Resources has secured over A$2.3 million in sales of its Pampafos organic phosphate fertiliser, marking a key transition to revenue-generating operations with deliveries scheduled through year-end.

Orthocell Ltd delivered a standout FY26 with 44% revenue growth to A$13.2 million, powered by accelerating US sales of its nerve repair product Remplir and a robust cash position supporting further expansion.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

City Chic Collective (ASX: CCX) reports a robust FY26 underlying EBITDA rise of 80%-95%, driven by strong ANZ sales and tight cost control amid a slight global revenue decline.

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

EQ Resources delivered its strongest quarterly tungsten output since early 2024, alongside record sales driven by higher prices and volumes, despite some operational hiccups in Spain.

Adairs posts 3.7% sales growth in FY26 but underlying EBIT dips 1.3%, weighed down by Focus on Furniture's ongoing struggles and a substantial non-cash impairment.

Xref Limited reported steady sales growth and improved cash flow in Q4 FY26, driven by core platform adoption and the rapid uptake of its new Xref.me product.

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.

Biome Australia has posted a 30% increase in FY26 sales revenue to $23.9 million, driven by strong domestic demand and strategic moves into onshore manufacturing and international markets.